Clinical and Translational Radiation Oncology

Papers
(The H4-Index of Clinical and Translational Radiation Oncology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility31
Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging30
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors25
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments22
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how22
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma19
Avoiding prostate bed radiation for the PSMA-PET detected nodal recurrence patient post prostatectomy16
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors16
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)16
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer15
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity15
Association between radiotherapy protocol variations and outcome in the CONVERT trial15
CD8-positive lymphocyte infiltration as a marker of anti-tumor immune response in rectal cancer: pre- and post-neoadjuvant radiotherapy comparison15
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study13
Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer13
2.239944934845